Clinical pharmacy in the era of an injection-free regimen for drug-resistant tuberculosis

  • N Misra King Dinuzulu Hospital Complex


Tuberculosis (TB) is the ninth leading cause of death worldwide with the 2019 global report placing South Africa (SA) among the six high TB burden countries.1 Globally, treatment success rates (cured and completed treatment) for multidrug resistant tuberculosis (MDR-TB) in the 2016 cohort were 56% and for extensively drug-resistant TB (XDR-TB) 39%. Despite major investments in medicine, diagnostics and programmatic management, low treatment success rates, high failure and loss to follow up rates have been reported for DR-TB globally and in SA.

Author Biography

N Misra, King Dinuzulu Hospital Complex

Pharmacy Manager, King Dinuzulu Hospital Complex, South Africa